Clinical Trial Update: The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating differences in cell-derived microparticles in patients with psoriasis treated with ustekinumab (Stelara). The current trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Psoriasis With Cell-derived Microparticles | Phase 4 | Status: UNKNOWN